The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Carmen Betriu

Department of Clinical Microbiology

Hospital Clínico San Carlos

Plaza Cristo Rey s/n

28040 Madrid



Name/email consistency: high



  • Department of Clinical Microbiology, Hospital Clínico San Carlos, Plaza Cristo Rey s/n, 28040 Madrid, Spain. 2001 - 2006
  • Servicio de Microbiología Clínica, Hospital Clínico San Carlos, Madrid, Spain. 1999 - 2005


  1. Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins. Betriu, C., Salso, S., Sánchez, A., Culebras, E., Gómez, M., Rodríguez-Avial, I., Picazo, J.J. Int. J. Antimicrob. Agents (2006) [Pubmed]
  2. In vitro activity of tigecycline against Bacteroides species. Betriu, C., Culebras, E., Gómez, M., Rodríguez-Avial, I., Picazo, J.J. J. Antimicrob. Chemother. (2005) [Pubmed]
  3. Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). Betriu, C., Rodríguez-Avial, I., Gómez, M., Culebras, E., Picazo, J.J. Diagn. Microbiol. Infect. Dis. (2005) [Pubmed]
  4. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Betriu, C., Culebras, E., Gómez, M., Rodríguez-Avial, I., Sánchez, B.A., Agreda, M.C., Picazo, J.J. Antimicrob. Agents Chemother. (2003) [Pubmed]
  5. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Betriu, C., Rodríguez-Avial, I., Sánchez, B.A., Gómez, M., Alvarez, J., Picazo, J.J. Antimicrob. Agents Chemother. (2002) [Pubmed]
  6. Endophthalmitis caused by Listeria monocytogenes. Betriu, C., Fuentemilla, S., Méndez, R., Picazo, J.J., García-Sánchez, J. J. Clin. Microbiol. (2001) [Pubmed]
  7. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains. Betriu, C., Sánchez, A., Palau, M.L., Gómez, M., Picazo, J.J. Antimicrob. Agents Chemother. (2001) [Pubmed]
  8. Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. Betriu, C., Redondo, M., Boloix, A., Gómez, M., Culebras, E., Picazo, J.J. J. Antimicrob. Chemother. (2001) [Pubmed]
  9. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Betriu, C., Redondo, M., Palau, M.L., Sánchez, A., Gómez, M., Culebras, E., Boloix, A., Picazo, J.J. Antimicrob. Agents Chemother. (2000) [Pubmed]
  10. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents. Betriu, C., Sánchez, A., Gómez, M., Palau, M.L., Picazo, J.J. J. Antimicrob. Chemother. (1999) [Pubmed]
  11. Peritonitis caused by Haemophilus parainfluenzae in a patient undergoing continuous ambulatory peritoneal dialysis. Betriu, C., Coronel, F., Martin, P., Picazo, J.J. J. Clin. Microbiol. (1999) [Pubmed]
  12. Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents. Betriu, C., Gómez, M., Palau, M.L., Sánchez, A., Picazo, J.J. Antimicrob. Agents Chemother. (1999) [Pubmed]
WikiGenes - Universities